Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 02/02/20011 min de leitura
John J. Ferrante et al; Withdrawal of Approval of 125 Abbreviated New Drug Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is withdrawing approval of 125 abbreviated new drug applications (ANDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for these applications.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →